Disease and Therapy Review Ovarian Cancer

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Leukemia Drug Pipeline Update 2014

Leukemia Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • by Bioseeker
  • July 2014

Leukemia includes a broad variety of histological separate disorders which make the leukemia market segmented. There are today 292 companies plus partners developing 417 leukemia drugs in 632 developmental projects in cancer. In addition, there are 5 suspended drugs and the accumulated number of ceased ...

Industries: Pathology

Lymphoma Drug Pipeline Update 2014

Lymphoma Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • by Bioseeker
  • July 2014

Lymphoma is a broad term encompassing a variety of cancers of the lymphatic system. There are today 249 companies plus partners developing 381 lymphoma drugs in 606 developmental projects in cancer. In addition, there are 3 suspended drugs and the accumulated number of ceased drugs over the last years ...

Industries: Pathology

Melanoma Drug Pipeline Update 2014

Melanoma Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • by Bioseeker
  • July 2014

Melanoma comprises just 5% of all skin cancers but it is the most deadly. High unmet needs still persist for this tumor type and despite three decades of extensive R&D, five-year survival of advanced patients remains below 20%. There are today 267 companies plus partners developing 316 drugs targeting ...

Industries: Pathology

Lymphoma Drug Pathway Analyzer 2014

Lymphoma Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • by Bioseeker
  • July 2014

Extra value: One year of free online updates included with this product There are today at least 350 targeted molecular therapies known to affect more than 235 specific intracellular signaling pathways for the treatment of lymphoma. The rational for this plethora of treatment strategies is based on ou ...

Industries: Pathology

Leukemia Drug Pathway Analyzer 2014

Leukemia Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • by Bioseeker
  • July 2014

Extra value: One year of free online updates included with this product There are today at least 379 targeted molecular therapies known to affect more than 244 specific intracellular signaling pathways for the treatment of leukemia. The rational for this plethora of treatment strategies is based on ou ...

Industries: Pathology

Melanoma Drug Pathway Analyzer 2014

Melanoma Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • by Bioseeker
  • July 2014

Extra value: One year of free online updates included with this product There are today at least 282 targeted molecular therapies known to affect more than 251 specific intracellular signaling pathways for the treatment of melanoma. The rational for this plethora of treatment strategies is based on ou ...

Industries: Pathology

Open-Angle Glaucoma - Pipeline Review, H2 2014

Open-Angle Glaucoma - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • July 2014
  • 89 pages

Open-Angle Glaucoma - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Open-Angle Glaucoma - Pipeline Review, H2 2014', provides an overview of the Open-Angle Glaucoma's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Open-Angle Glaucoma, ...

Industries: Pathology | Countries: World

Diabetic Gastroparesis - Pipeline Review, H2 2014

Diabetic Gastroparesis - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • July 2014
  • 59 pages

Diabetic Gastroparesis - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Diabetic Gastroparesis - Pipeline Review, H2 2014', provides an overview of the Diabetic Gastroparesis's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Diabetic ...

Industries: Pathology | Countries: World

Anaplastic Astrocytoma - Pipeline Review, H2 2014

Anaplastic Astrocytoma - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • July 2014
  • 56 pages

Anaplastic Astrocytoma - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Anaplastic Astrocytoma - Pipeline Review, H2 2014', provides an overview of the Anaplastic Astrocytoma's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Anaplastic ...

Industries: Pathology | Countries: World

AIDS - Related Kaposi%s Sarcoma - Pipeline Review, H2 2014

AIDS - Related Kaposi%s Sarcoma - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • July 2014
  • 57 pages

AIDS - Related Kaposi's Sarcoma - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘AIDS - Related Kaposi's Sarcoma - Pipeline Review, H2 2014', provides an overview of the AIDS - Related Kaposi's Sarcoma's therapeutic pipeline. This report provides comprehensive information on the therapeutic ...

Industries: Pathology | Countries: World, United States

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 618 4302

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.